We are live on ! Find out more
SSKN

Strata Skin Sciences

Delisted

SSKN was delisted on the 18th of February, 2026.

18 hedge funds and large institutions have $1.48M invested in Strata Skin Sciences in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

2.07% more ownership

Funds ownership: 0.44%2.51% (+2.1%)

3% more capital invested

Capital invested by funds: $1.44M → $1.48M (+$48.7K)

10% less funds holding

Funds holding: 2018 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change

SSKN Hedge Fund Activity: Q2 2017 in Review

18 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q2 2017, worth a combined $1.48M — up 3.4% from $1.44M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of SSKN and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was Sabby Management, adding an estimated $260K. The largest seller was Broadfin Capital, cutting an estimated $350K.

  • 18 institutional investors held Strata Skin Sciences (SSKN) as of Q2 2017, down from 20 in Q1 2017.
  • Funds reported $1.48M of Strata Skin Sciences stock for Q2 2017, up 3.4% quarter-over-quarter.
  • 3 funds opened new Strata Skin Sciences positions in Q2 2017 and 5 closed out, a net change of -2 holders.
  • The largest Strata Skin Sciences buyer in Q2 2017 was Sabby Management, an estimated $260K added.
  • The largest Strata Skin Sciences seller in Q2 2017 was Broadfin Capital, an estimated $350K sold.

Based on aggregated 13F filings for Q2 2017.